EP2109454A4 - Compositions pharmaceutiques à base de glp-1 - Google Patents

Compositions pharmaceutiques à base de glp-1

Info

Publication number
EP2109454A4
EP2109454A4 EP07868132.7A EP07868132A EP2109454A4 EP 2109454 A4 EP2109454 A4 EP 2109454A4 EP 07868132 A EP07868132 A EP 07868132A EP 2109454 A4 EP2109454 A4 EP 2109454A4
Authority
EP
European Patent Office
Prior art keywords
glp
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07868132.7A
Other languages
German (de)
English (en)
Other versions
EP2109454A1 (fr
Inventor
Zheng Xin Dong
Roland Cherif-Cheikh
Rigol Jose-Antonio Cordero
Miravete Resurreccion Alloza
Frederic Lacombe
Maestre Maria Dolores Tobalina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Ipsen Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/647,746 external-priority patent/US20070244034A1/en
Application filed by Ipsen Pharma SAS filed Critical Ipsen Pharma SAS
Publication of EP2109454A1 publication Critical patent/EP2109454A1/fr
Publication of EP2109454A4 publication Critical patent/EP2109454A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP07868132.7A 2006-12-29 2007-12-31 Compositions pharmaceutiques à base de glp-1 Withdrawn EP2109454A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/647,746 US20070244034A1 (en) 2005-06-30 2006-12-29 GLP-1 pharmaceutical compositions
US90058607A 2007-09-12 2007-09-12
PCT/US2007/026490 WO2008082656A1 (fr) 2006-12-29 2007-12-31 Compositions pharmaceutiques à base de glp-1

Publications (2)

Publication Number Publication Date
EP2109454A1 EP2109454A1 (fr) 2009-10-21
EP2109454A4 true EP2109454A4 (fr) 2013-06-05

Family

ID=39588950

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07868132.7A Withdrawn EP2109454A4 (fr) 2006-12-29 2007-12-31 Compositions pharmaceutiques à base de glp-1

Country Status (6)

Country Link
EP (1) EP2109454A4 (fr)
JP (1) JP2010523473A (fr)
KR (1) KR101247665B1 (fr)
CN (1) CN101668535B (fr)
AU (1) AU2007340369C1 (fr)
WO (1) WO2008082656A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2216042A1 (fr) * 2009-02-09 2010-08-11 Ipsen Pharma S.A.S. Compositions pharmaceutiques analogues au GLP-1
KR101609302B1 (ko) * 2010-05-17 2016-04-06 베타 파머수티컬 컴퍼니 리미티드 새로운 글루카곤 유사 펩타이드 유사체, 조성물, 및 사용 방법
CN103405753B (zh) * 2013-08-13 2016-05-11 上海仁会生物制药股份有限公司 稳定的促胰岛素分泌肽水针药物组合物
EP3727332A1 (fr) * 2017-12-21 2020-10-28 Sanofi Composition pharmaceutique liquide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007005738A2 (fr) * 2005-06-30 2007-01-11 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Compositions pharmaceutiques de glp-1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902434A (en) * 1988-10-21 1990-02-20 The Drackett Company Fabric treatment
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
US6284727B1 (en) * 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US6903186B1 (en) * 1998-12-07 2005-06-07 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S Analogues of GLP-1
JP2007514752A (ja) * 2003-12-16 2007-06-07 ソシエテ・ドゥ・コンセイユ・ドゥ・ルシェルシュ・エ・ダプリカーション・シャンティフィック・エス・ア・エス Ｇｌｐ−１医薬組成物

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007005738A2 (fr) * 2005-06-30 2007-01-11 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Compositions pharmaceutiques de glp-1

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2008082656A1 *

Also Published As

Publication number Publication date
CN101668535A (zh) 2010-03-10
AU2007340369B2 (en) 2011-12-22
KR20090096739A (ko) 2009-09-14
AU2007340369C1 (en) 2013-05-02
EP2109454A1 (fr) 2009-10-21
KR101247665B1 (ko) 2013-04-02
JP2010523473A (ja) 2010-07-15
CN101668535B (zh) 2017-07-28
WO2008082656A1 (fr) 2008-07-10
AU2007340369A1 (en) 2008-07-10

Similar Documents

Publication Publication Date Title
IL247741A0 (en) pharmaceutical preparations
EP2001498A4 (fr) Compositions pharmaceutiques
IL194176A0 (en) Pharmaceutical compositions
GB0625322D0 (en) Pharmaceutical compositions
EP2025337A4 (fr) Composition pharmaceutique externe
EP2005959A4 (fr) Composition pharmaceutique externe
EP2005958A4 (fr) Composition pharmaceutique externe
HK1138732A1 (en) Pharmaceutical compositions
EP2222313A4 (fr) Compositions pharmaceutiques
GB0610322D0 (en) Novel pharmaceutical compositions
GB0608724D0 (en) Novel Pharmaceutical Compositions
EP1904525A4 (fr) Compositions pharmaceutiques de glp-1
EP2146695A4 (fr) Compositions pharmaceutiques
GB0709811D0 (en) Pharmaceutical compositions
EP2124959A4 (fr) Composition pharmaceutique
GB0707127D0 (en) Pharmaceutical compositions
EP2109454A4 (fr) Compositions pharmaceutiques à base de glp-1
GB0712454D0 (en) Pharmaceutical compositions
GB2454923B (en) Pharmaceutical compositions
IL194844A0 (en) New synergistic pharmaceutical composition
IL201394A0 (en) Niacin - based pharmaceutical compositions
ZA200904725B (en) GLP-1 Pharmaceutical compositions
HU0600938D0 (en) Pharmaceutical compositions
ZA200808030B (en) Pharmaceutical compositions
HU0600939D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090724

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20130507

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/26 20060101AFI20130429BHEP

Ipc: A61K 47/02 20060101ALI20130429BHEP

Ipc: A61K 47/12 20060101ALI20130429BHEP

Ipc: A61K 31/70 20060101ALI20130429BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20131207